BR112016030599A8 - novos derivados de aminoalquilbenzotiazepina e suas utilizações - Google Patents

novos derivados de aminoalquilbenzotiazepina e suas utilizações

Info

Publication number
BR112016030599A8
BR112016030599A8 BR112016030599A BR112016030599A BR112016030599A8 BR 112016030599 A8 BR112016030599 A8 BR 112016030599A8 BR 112016030599 A BR112016030599 A BR 112016030599A BR 112016030599 A BR112016030599 A BR 112016030599A BR 112016030599 A8 BR112016030599 A8 BR 112016030599A8
Authority
BR
Brazil
Prior art keywords
new
aminoalkylbenzothiazepine
derivatives
aminoalkylbenzothiazepine derivatives
constipation
Prior art date
Application number
BR112016030599A
Other languages
English (en)
Other versions
BR112016030599B1 (pt
BR112016030599A2 (pt
Inventor
Won-Hyuk Jung
Seung In Kim
Seung Hee Ji
Dong Hyun Ko
Seog Beom Song
Keun Ho Lee
Hyung Jin Jun
Dong Kyu Kim
Dong Hyun Kim
Original Assignee
Cj Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Healthcare Corp filed Critical Cj Healthcare Corp
Publication of BR112016030599A2 publication Critical patent/BR112016030599A2/pt
Publication of BR112016030599A8 publication Critical patent/BR112016030599A8/pt
Publication of BR112016030599B1 publication Critical patent/BR112016030599B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/02—Monocyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/24—Monocyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with a seven-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/06—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

novos derivados de aminoalquilbenzotiazepina e suas utilizações. a presente invenção refere-se a um novo derivado de aminoalquilobenzotiazepina ou a um seu sal farmaceuticamente aceitável, e a uma composição farmacêutica para a prevenção ou tratamento de obstipação que compreende o mesmo como ingrediente ativo.
BR112016030599-0A 2014-10-20 2015-08-28 Novos derivados de aminoalquilbenzotiazepina e suas utilizações BR112016030599B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20140141869 2014-10-20
KR10-2014-0141869 2014-10-20
KR10-2015-0069949 2015-05-19
KR1020150069949A KR101674806B1 (ko) 2014-10-20 2015-05-19 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
PCT/KR2015/009044 WO2016064082A2 (ko) 2014-10-20 2015-08-28 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도

Publications (3)

Publication Number Publication Date
BR112016030599A2 BR112016030599A2 (pt) 2017-08-15
BR112016030599A8 true BR112016030599A8 (pt) 2021-07-06
BR112016030599B1 BR112016030599B1 (pt) 2023-07-04

Family

ID=

Also Published As

Publication number Publication date
CA2951824C (en) 2019-01-08
UY36342A (es) 2016-06-01
AU2015336400A1 (en) 2016-12-22
RU2017103920A (ru) 2018-11-22
JP2017527589A (ja) 2017-09-21
CN106573902B (zh) 2019-10-08
CA2951824A1 (en) 2016-04-28
MX2016016593A (es) 2017-04-27
JP6386171B2 (ja) 2018-09-05
DK3210977T3 (da) 2019-07-01
CN106573902A (zh) 2017-04-19
ES2729305T3 (es) 2019-10-31
EP3210977B1 (en) 2019-03-20
AU2015336400B8 (en) 2018-04-05
IL250668B (en) 2019-07-31
KR101674806B1 (ko) 2016-11-10
AU2015336400B2 (en) 2017-12-07
KR20160047378A (ko) 2016-05-02
BR112016030599A2 (pt) 2017-08-15
EP3210977A2 (en) 2017-08-30
US20170283386A1 (en) 2017-10-05
EP3210977A4 (en) 2018-04-11
AU2015336400A8 (en) 2018-04-05
IL250668A0 (en) 2017-04-30
RU2679891C2 (ru) 2019-02-14
RU2017103920A3 (pt) 2018-11-22
AR102204A1 (es) 2017-02-08
WO2016064082A2 (ko) 2016-04-28
WO2016064082A3 (ko) 2016-06-09
US9890129B2 (en) 2018-02-13

Similar Documents

Publication Publication Date Title
UY36342A (es) Nuevos derivados de aminoalquilbenzotiazepinas y usos de los mismos
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
CL2018002718A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue.
CL2018002758A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue.
BR112017011972A2 (pt) derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais
CL2018002784A1 (es) Derivados de compuestos de indol sustituidos como inhibidores de la replicación vírica del dengue.
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
CR20190446A (es) Derivados de indolina sustituidos como inhibidores de la replicación viral de dengue
BR112018070123A2 (pt) oxiesterós e métodos de uso dos mesmos
UY36340A (es) Derivados de indoles mono- o disustituidos como inhibidores de la replicación del virus del dengue
ECSP16078782A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
CL2016002091A1 (es) Compuesto de triazina y su uso para fines medicinales
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
BR112016030733A2 (pt) Derivados de indano e indolina e uso dos mesmos como ativadores de guanilato ciclase solúveis
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
BR112017009012A2 (pt) derivados de anel benzo de seis membros como inibidor de dpp-4 e seu uso
BR112017001221A2 (pt) derivados de indolizina que são aplicáveis a doenças neurodegenerativas
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
BR112017004580A2 (pt) composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento.
BR112016020556A8 (pt) compostos, composição farmacêutica, método de modulação da atividade do receptor de grelina, método para o tratamento de uma doença e usos de um composto
BR112015018442A2 (pt) compostos de derivados de ciclohexeno biaril- ou heterocíclico biaril-substituído como inibidores de cetp
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
CL2017002229A1 (es) Inhibidores de bace1.
BR112019001024A2 (pt) combinação de um inibidor de bcl-2 e um inibidor de mcl-1, seus usos e composições farmacêuticas
BR112017004595A2 (pt) composição farmacêutica contendo inibidor de transportador de fosfato dependente de sódio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25D Requested change of name of applicant approved

Owner name: HK. INNO.N CORPORATION (KR)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/08/2015, OBSERVADAS AS CONDICOES LEGAIS